The clinical effects of prolonged intravenous infusion of 5-fluoro-2'-deoxyuridine.
D007516:Adenoma, Islet Cell / Q000188:drug therapy; D000368:Aged; D001943:Breast Neoplasms / Q000188:drug therapy; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D003110:Colonic Neoplasms / Q000188:drug therapy; D005260:Female; D005467:Floxuridine / Q000633:toxicity*; D006801:Humans; D007263:Infusions, Parenteral; D008025:Ligases / Q000378:metabolism; D008175:Lung Neoplasms / Q000188:drug therapy; D008206:Lymphatic Diseases / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009062:Mouth Neoplasms / Q000188:drug therapy; D010190:Pancreatic Neoplasms / Q000188:drug therapy; D012004:Rectal Neoplasms / Q000188:drug therapy; D012878:Skin Neoplasms / Q000188:drug therapy; D013274:Stomach Neoplasms / Q000188:drug therapy
D005467:Floxuridine; D008025:Ligases